George Cusatis
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 2
- Protein Degradation and Inhibitors 1
- 14-3-3 protein interactions 1
- Oncology 5
- Drug Transport and Resistance Mechanisms 3
- Pancreatic and Hepatic Oncology Research 1
- Chemokine receptors and signaling 1
- Co-authors
- Alex Sparreboom (4 shared papers)Manuel Hidalgo (6 shared papers)Sharyn D. Baker (3 shared papers)Susan E. Bates (2 shared papers)Jaap Verweij (2 shared papers)Roxann Ingersoll (2 shared papers)Robert W. Robey (1 shared paper)Jing Li (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Cancer Biology & Therapy (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Pharmacogenomics (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
George Cusatis
8 papers receiving 543 citations
Peers
Comparison fields: 5 of 64
- Oncology 394
- Pharmacology 91
- Pediatrics, Perinatology and Child Health 95
- Pulmonary and Respiratory Medicine 106
- Infectious Diseases 50
Countries citing papers authored by George Cusatis
This map shows the geographic impact of George Cusatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Cusatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Cusatis more than expected).
Fields of papers citing papers by George Cusatis
This network shows the impact of papers produced by George Cusatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Cusatis. The network helps show where George Cusatis may publish in the future.
Co-authors
The 25 scholars most cited alongside George Cusatis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 201 | |
| 2 | 2007 | 160 | |
| 3 | 2005 | 63 | |
| 4 | 2008 | 60 | |
| 5 | 2012 | 45 | |
| 6 | 2007 | 21 | |
| 7 | 2006 | 13 | |
| 8 | In vivo testing of Mycophenolic acid (MPA) in primary pancreatic cancer (PaCa) xenografts | 2007 | 1 |
About George Cusatis
George Cusatis is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 564 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Click Chemistry and Applications (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Protein Degradation and Inhibitors (1 paper), 14-3-3 protein interactions (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Oncology (394 citations), Pharmacology (91 citations), Pediatrics, Perinatology and Child Health (95 citations), Pulmonary and Respiratory Medicine (106 citations) and Infectious Diseases (50 citations). George Cusatis has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Alex Sparreboom, Manuel Hidalgo, Sharyn D. Baker, Susan E. Bates, Jaap Verweij, Roxann Ingersoll, Robert W. Robey, Jing Li, Julie R. Brahmer and Vienna Ludovini. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Cancer Biology & Therapy, JNCI Journal of the National Cancer Institute and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.